U.S. futures lower after Citi, Merril injections, retail report - MarketWatch
Financials were in focus, as Citigroup (C:
C
Sponsored by:
, , ) said it would cut its dividend by 40%, and get a $12.5 billion capital injection from investors including Singapore and Kuwait after reporting a $9.8 billion quarterly loss. Merrill Lynch (MER:
MER
Sponsored by:
, , ) meanwhile announced it was getting a $6.6 billion injection, notably from sovereign wealth funds of Kuwait and Korea as well as Japan's Mizuho Corporate Bank (MFG:MFG
Sponsored by:
, , ) . Merrill Lynch lost 1.9% in pre-open deals, and Citi slipped 1.6%.
Intel (INTC:
INTC
Sponsored by:
, , ) after the close will report its quarterly performance. Genentech (DNA:
DNA
Sponsored by:
, , ) fell 2.3% in pre-open trade after the biotech said late Monday that its fourth-quarter profit rose 6%. AstraZeneca (AZN:
AZN
Sponsored by:
, , ) said it would test its Crestor drug against Pfizer's (PFE:PFE
The Nikkei 225 fell below the 14,000 level in Tokyo for the first time since November 2005. Losses for drugmakers as well as retailers pulled the FTSE 100 down 1.6% in London.
No comments:
Post a Comment
Your spam will not get posted on my blog. No wizetrade spammers etc